MENU
CMPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Compass Therapeutics (CMPX) Ownership - Who owns Compass Therapeutics?
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more
Profile
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
201.89M
P/E Ratio
N/A
Total Cash
126.72M
Projected Growth
N/A
Total Debt
6.63M
Revenue
850K
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash/Share
0.92
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CMPX
Capitalization
202M
P/E Ratio
N/A
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
0.92
Total Debt
6.63M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
850K
ROE
N/A
Book Value
125M
P/B Ratio
1.61
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
14.96
Current Revenue Per Employee
26562.50
Dividends Per Share - Security
N/A
EBITDA
-54.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.22
Shares Held By Institutions
187M
Shares Outstanding - Current
138M
Total Liabilities
15.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.690
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com